TipRanks

Vincent S LoPriore Insider Profile

4 Followers
Vincent S LoPriore, EC, Director at Hepion Pharmaceuticals, holds 30.50M shares in Hepion Pharmaceuticals (Ticker: HEPA), holds ― shares in Canton Strategic Holdings (Ticker: CNTN). Most recently, Vincent S LoPriore Bought ― shares of Hepion Pharmaceuticals on Aug 12, 2026 for an estimated value of $400.00K.
tipranks
Vincent S LoPriore

Vincent S LoPriore
Hepion Pharmaceuticals (HEPA)
EC, Director

Ranked #37,797 out of 109,106 Corporate Insiders

Profitable Transactions

100%
2 out of 2 Profitable Transactions

Average Return

+35.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
100.00%
0.00%
A breakdown of Vincent S LoPriore's holdings

Insider Roles

Hepion Pharmaceuticals
(HEPA)
EC, Director
Canton Strategic Holdings
(CNTN)
Executive Chairman, Director, Ten Percent Owner
Roles that Vincent S LoPriore holds in companies

Most Profitable Insider Trade

Stock:
Hepion Pharmaceuticals
(HEPA)
Rating:Informative Buy
Date:Aug 12, 2026 - Today
Return:+49.00%
The most profitable trade made by Vincent S LoPriore

Vincent S LoPriore's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Hepion Pharmaceuticals
Aug 12, 2026
EC, Director
Informative Buy
400.00K
$2.65M
Canton Strategic Holdings
―
Executive Chairman, Director, Ten Percent Owner
―
―
List of latest transactions for each holding click on a transaction to see Vincent S LoPriore's performance on stock

Vincent S LoPriore insider profile FAQ

What is the percentage of profitable transactions made by Vincent S LoPriore?
The percentage of profitable transactions made by Vincent S LoPriore is 100%.
    What is the average return per transaction made by Vincent S LoPriore?
    The average return per transaction made by Vincent S LoPriore is 35.70%.
      What stocks does Vincent S LoPriore hold?
      Vincent S LoPriore holds: HEPA, CNTN stocks.
        What was Vincent S LoPriore’s latest transaction?
        Vincent S LoPriore latest transaction was an Informative Buy of $400.00K.
          What was Vincent S LoPriore's most profitable transaction?
          Vincent S LoPriore’s most profitable transaction was an Informative Buy of HEPA stock on August 12, 2026. The return on the trade was 49.00%.
            What is Vincent S LoPriore's role in Hepion Pharmaceuticals?
            Vincent S LoPriore's role in Hepion Pharmaceuticals is EC, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.